Vrk Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 407.22%
- Profit Growth 316.87%
- Ebitda 1618.20%
- Net Worth 11.58%
- Total Assets 65.21%
About Vrk Biotech
Vrk Biotech Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2017 (Seven years and 11 months 0 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrakant Pathak, Vinod Kulkarni, Sankalp Kulkarni, and Three other members serve as directors at the Company.
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304PN2017PTC169637
- Company No.
169637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Vrk Biotech?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrakant Pathak  | Director | 27-Mar-2017 | Current |
| Vinod Kulkarni | Director | 27-Mar-2017 | Current |
| Sankalp Kulkarni | Director | 17-Apr-2018 | Current |
| Varad Kulkarni | Director | 17-Apr-2018 | Current |
| Vrishali Kulkarni | Director | 17-Apr-2018 | Current |
| Saurabh Kulkarni | Director | 17-Apr-2018 | Current |
Financial Performance of Vrk Biotech.
Vrk Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 407.22% increase. The company also saw a substantial improvement in profitability, with a 316.87% increase in profit. The company's net worth Soared by an impressive increase of 11.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vrk Biotech?
In 2021, Vrk Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vrk Biotech?
Unlock and access historical data on people associated with Vrk Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vrk Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vrk Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.